Winning Points Advisors, LLC Cytosorbents Corp Transaction History

Winning Points Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 07, 2022	SELL	$1.39 - $2.46 $2,780 - $4,920	-2,000 Reduced 8.03%	22,900 $33,000
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.22 $76,560 - $140,070	-43,500 Reduced 63.6%	24,900 $54,000
Q1 2022 Apr 27, 2022	BUY	$2.88 - $4.23 $196,992 - $289,332	68,400 New	68,400 $218,000
Q4 2021 Feb 16, 2022	SELL	$4.05 - $8.11 $349,110 - $699,082	-86,200 Closed	0 $0
Q3 2021 Nov 17, 2021	SELL	$7.0 - $9.71 $354,900 - $492,297	-50,700 Reduced 37.03%	86,200 $701,000

Q2 2021 Aug 16, 2021	SELL	$7.55 - $9.42 $16,610 - $20,724	-2,200 Reduced 1.58%	136,900 $1.04 Million
Q4 2020 Feb 01, 2021	SELL	$7.65 - $8.98 $30,600 - $35,920	-4,000 Reduced 2.8%	139,100 $1.11 Million
Q3 2020 Nov 13, 2020	BUY	$7.37 - $11.54 $638,242 - $999,363	86,600 Added 153.27%	143,100 $1.14 Million
Q2 2020 Aug 18, 2020	BUY	$6.28 - $10.59 $135,020 - $227,685	21,500 Added 61.43%	56,500 $559,000
Q1 2020 Apr 14, 2020	BUY	$3.77 - $7.73 $18,850 - $38,650	5,000 Added 16.67%	35,000 $269,000
Q4 2019 Feb 03, 2020	BUY	$3.61 - $5.22 $108,300 - $156,600	30,000 New	30,000 $115,000

17.8M

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $39.7M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Winning Points Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Winning Points Advisors, LLC with notifications on news.